{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T17:52:19Z","timestamp":1789321939870,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T00:00:00Z","timestamp":1601683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T00:00:00Z","timestamp":1601683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673051"],"award-info":[{"award-number":["81673051"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872519"],"award-info":[{"award-number":["81872519"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Psoriasis is characterized by keratinocyte hyperproliferation. While significant progress has been made in understanding the molecular mechanism regulating the proliferation of keratinocytes, little is known about the epigenetic factors that control this process. EZH2 and EZH2 mediated trimethylation of histone H3 lysine 27 (H3K27me3) was previously shown ectopically expressed in carcinoma and mediated proliferation, thereby we sought to clarify the role of EZH2\u2013H3K27me3 in the proliferation of psoriatic keratinocyte. Interestingly, we found that EZH2 and H3K27me3 were both overexpressed in the epidermis of psoriatic lesional skin compared to normal skin. In vitro, the expression of EZH2 and H3K27me3 was stimulated in human keratinocytes treated with mixture of psoriasis-related cytokines pool (TNF-\u03b1, IFN-\u03b3, IL-17A, and IL-22). Knockdown of EZH2 significantly reduced keratinocyte proliferative activity. Results from mRNA microarray analysis suggested that Kallikrein-8 (KLK8) might be the target gene of EZH2 in psoriatic keratinocytes. Overexpression or knockdown KLK8 could partially reverse the abnormal proliferation of keratinocytes caused by knockdown or overexpression of EZH2. In vivo, the inhibitor of EZH2, GSK126 could ameliorate the imiquimod-induced psoriasiform lesion. These results suggest that EZH2 might be a therapeutic target for the treatment of psoriasis.<\/jats:p>","DOI":"10.1038\/s41419-020-03028-1","type":"journal-article","created":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T16:02:29Z","timestamp":1601740949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["EZH2-dependent epigenetic modulation of histone H3 lysine-27 contributes to psoriasis by promoting keratinocyte proliferation"],"prefix":"10.1038","volume":"11","author":[{"given":"Tongmei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erle","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5842-8080","authenticated-orcid":false,"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,3]]},"reference":[{"key":"3028_CR1","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1096\/fj.10-172288","volume":"25","author":"R Sestito","year":"2011","unstructured":"Sestito, R. et al. STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation. FASEB J. 25, 916 (2011).","journal-title":"FASEB J."},{"key":"3028_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cyto.2012.06.316","volume":"60","author":"A Mitra","year":"2012","unstructured":"Mitra, A., Raychaudhuri, S. K. & Raychaudhuri, S. P. IL-22 induced cell proliferation is regulated by PI3K\/Akt\/mTOR signaling cascade. Cytokine 60, 38 (2012).","journal-title":"Cytokine"},{"key":"3028_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.immuni.2012.04.010","volume":"37","author":"Y Lai","year":"2012","unstructured":"Lai, Y. et al. The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury. Immunity 37, 74 (2012).","journal-title":"Immunity"},{"key":"3028_CR4","doi-asserted-by":"crossref","unstructured":"Ekman, A. K., Bivik, E. C., Rundquist, I. & Enerback, C. IL-17 and IL-22 promote keratinocyte stemness in the germinative compartment in psoriasis. J. Invest. Dermatol. 139, 1564\u20131573 (2019).","DOI":"10.1016\/j.jid.2019.01.014"},{"key":"3028_CR5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1684\/ejd.2014.2505","volume":"25","author":"A Montagner","year":"2015","unstructured":"Montagner, A., Wahli, W. & Tan, N. S. Nuclear receptor peroxisome proliferator activated receptor (PPAR) beta\/delta in skin wound healing and cancer. Eur. J. Dermatol. 25, 4 (2015).","journal-title":"Eur. J. Dermatol."},{"key":"3028_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/jid.2009.265","volume":"130","author":"J Nousbeck","year":"2010","unstructured":"Nousbeck, J. et al. Insulin-like growth factor-binding protein 7 regulates keratinocyte proliferation, differentiation and apoptosis. J. Invest. Dermatol. 130, 378 (2010).","journal-title":"J. Invest. Dermatol."},{"key":"3028_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes, M. A., Suarez-Farinas, M. & Krueger, J. G. Immunology of psoriasis. Annu. Rev. Immunol. 32, 227 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"3028_CR8","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"W Boehncke","year":"2015","unstructured":"Boehncke, W. & Sch\u00f6n, M. P. Psoriasis. Lancet 386, 983 (2015).","journal-title":"Lancet"},{"key":"3028_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002454","volume":"8","author":"K Gervin","year":"2012","unstructured":"Gervin, K. et al. DNA methylation and gene expression changes in monozygotic twins discordant for psoriasis: identification of epigenetically dysregulated genes. PLoS Genet. 8, e1002454 (2012).","journal-title":"PLoS Genet."},{"key":"3028_CR10","doi-asserted-by":"publisher","first-page":"36542","DOI":"10.1074\/jbc.M804578200","volume":"283","author":"S Beyer","year":"2008","unstructured":"Beyer, S., Kristensen, M. M., Jensen, K. S., Johansen, J. V. & Staller, P. The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. J. Biol. Chem. 283, 36542 (2008).","journal-title":"J. Biol. Chem."},{"key":"3028_CR11","doi-asserted-by":"crossref","unstructured":"Casciello, F., Windloch, K., Gannon, F. & Lee, J. S. Functional role of G9a histone methyltransferase in cancer. Front. Immunol. 6, 487 (2015).","DOI":"10.3389\/fimmu.2015.00487"},{"key":"3028_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.addr.2015.10.006","volume":"95","author":"K Shinjo","year":"2015","unstructured":"Shinjo, K. & Kondo, Y. Targeting cancer epigenetics: linking basic biology to clinical medicine. Adv. Drug Deliv. Rev. 95, 56 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"3028_CR13","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1128\/MCB.02180-06","volume":"27","author":"RJ Klose","year":"2007","unstructured":"Klose, R. J. et al. Demethylation of histone H3K36 and H3K9 by Rph1: a vestige of an H3K9 methylation system in Saccharomyces cerevisiae? Mol. Cell. Biol. 27, 3951 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"3028_CR14","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1038\/onc.2011.121","volume":"30","author":"J Fullgrabe","year":"2011","unstructured":"Fullgrabe, J., Kavanagh, E. & Joseph, B. Histone onco-modifications. Oncogene 30, 3391 (2011).","journal-title":"Oncogene"},{"key":"3028_CR15","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.molcel.2008.11.004","volume":"32","author":"R Margueron","year":"2008","unstructured":"Margueron, R. et al. Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. Mol. Cell 32, 503 (2008).","journal-title":"Mol. Cell"},{"key":"3028_CR16","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1158\/1078-0432.CCR-12-2505","volume":"19","author":"OM Gannon","year":"2013","unstructured":"Gannon, O. M., Merida, D. L. L., Endo-Munoz, L., Hazar-Rethinam, M. & Saunders, N. A. Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation. Clin. Cancer. Res. 19, 428 (2013).","journal-title":"Clin. Cancer. Res."},{"key":"3028_CR17","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1039\/C5MB00233H","volume":"11","author":"Y Qi","year":"2015","unstructured":"Qi, Y. et al. Genome-wide transcriptional profiling analysis reveals annexin A6 as a novel EZH2 target gene involving gastric cellular proliferation. Mol. Biosyst. 11, 1980 (2015).","journal-title":"Mol. Biosyst."},{"key":"3028_CR18","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.18632\/oncotarget.3030","volume":"6","author":"B Lin","year":"2015","unstructured":"Lin, B. et al. Global analysis of H3K4me3 and H3K27me3 profiles in glioblastoma stem cells and identification of SLC17A7 as a bivalent tumor suppressor gene. Oncotarget 6, 5369 (2015).","journal-title":"Oncotarget"},{"key":"3028_CR19","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1101\/gad.1673508","volume":"22","author":"GL Sen","year":"2008","unstructured":"Sen, G. L., Webster, D. E., Barragan, D. I., Chang, H. Y. & Khavari, P. A. Control of differentiation in a self-renewing mammalian tissue by the histone demethylase JMJD3. Gene Dev. 22, 1865 (2008).","journal-title":"Gene Dev."},{"key":"3028_CR20","doi-asserted-by":"publisher","first-page":"718725","DOI":"10.1155\/2012\/718725","volume":"2012","author":"FX Bernard","year":"2012","unstructured":"Bernard, F. X. et al. Keratinocytes under fire of proinflammatory cytokines: bona fide innate immune cells involved in the physiopathology of chronic atopic dermatitis and psoriasis. J. Allergy 2012, 718725 (2012).","journal-title":"J. Allergy"},{"key":"3028_CR21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1074\/jbc.M110.125310","volume":"286","author":"A Eissa","year":"2011","unstructured":"Eissa, A., Amodeo, V., Smith, C. R. & Diamandis, E. P. Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade. J. Biol. Chem. 286, 687 (2011).","journal-title":"J. Biol. Chem."},{"key":"3028_CR22","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.4049\/jimmunol.1403196","volume":"194","author":"J Bai","year":"2015","unstructured":"Bai, J. et al. Epigenetic downregulation of SFRP4 contributes to epidermal hyperplasia in psoriasis. J. Immunol. 194, 4185 (2015).","journal-title":"J. Immunol."},{"key":"3028_CR23","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1038\/jid.2015.128","volume":"135","author":"X Gu","year":"2015","unstructured":"Gu, X., Nylander, E., Coates, P. J., Fahraeus, R. & Nylander, K. Correlation between reversal of DNA methylation and clinical symptoms in psoriatic epidermis following narrow-band UVB phototherapy. J. Invest. Dermatol. 135, 2077 (2015).","journal-title":"J. Invest. Dermatol."},{"key":"3028_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jdermsci.2010.07.011","volume":"60","author":"P Zhang","year":"2010","unstructured":"Zhang, P., Su, Y., Chen, H., Zhao, M. & Lu, Q. Abnormal DNA methylation in skin lesions and PBMCs of patients with psoriasis vulgaris. J. Dermatol. Sci. 60, 40 (2010).","journal-title":"J. Dermatol. Sci."},{"key":"3028_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00403-013-1432-8","volume":"306","author":"GT Park","year":"2014","unstructured":"Park, G. T., Han, J., Park, S., Kim, S. & Kim, T. DNA methylation analysis of CD4+ T cells in patients with psoriasis. Arch. Dermatol. Res. 306, 259 (2014).","journal-title":"Arch. Dermatol. Res."},{"key":"3028_CR26","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1684\/ejd.2011.1383","volume":"21","author":"P Zhang","year":"2011","unstructured":"Zhang, P., Su, Y., Zhao, M., Huang, W. & Lu, Q. Abnormal histone modifications in PBMCs from patients with psoriasis vulgaris. Eur. J. Dermatol. 21, 552 (2011).","journal-title":"Eur. J. Dermatol."},{"key":"3028_CR27","first-page":"111","volume":"13","author":"RM Trowbridge","year":"2014","unstructured":"Trowbridge, R. M. & Pittelkow, M. R. Epigenetics in the pathogenesis and pathophysiology of psoriasis vulgaris. J. Drugs Dermatol. 13, 111 (2014).","journal-title":"J. Drugs Dermatol."},{"key":"3028_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.190","volume":"3","author":"W Chen","year":"2012","unstructured":"Chen, W. et al. Grainyhead-like 2 (GRHL2) inhibits keratinocyte differentiation through epigenetic mechanism. Cell Death Dis. 3, e450 (2012).","journal-title":"Cell Death Dis."},{"key":"3028_CR29","doi-asserted-by":"crossref","unstructured":"Pollock, R. A., Abji, F. & Gladman, D. D. Epigenetics of psoriatic disease: a systematic review and critical appraisal. J. Autoimmun. 78, 29\u201338 (2016).","DOI":"10.1016\/j.jaut.2016.12.002"},{"key":"3028_CR30","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/exd.13790","volume":"27","author":"MC Ovejero-Benito","year":"2018","unstructured":"Ovejero-Benito, M. C. et al. Histone modifications associated with biological drug response in moderate-to-severe psoriasis. Exp. Dermatol. 27, 1361 (2018).","journal-title":"Exp. Dermatol."},{"key":"3028_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1515\/cclm-2012-0251","volume":"51","author":"A Eissa","year":"2013","unstructured":"Eissa, A. et al. Serum kallikrein-8 correlates with skin activity, but not psoriatic arthritis, in patients with psoriatic disease. Clin. Chem. Lab. Med. 51, 317 (2013).","journal-title":"Clin. Chem. Lab. Med."},{"key":"3028_CR32","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/exd.12794","volume":"24","author":"S Iinuma","year":"2015","unstructured":"Iinuma, S. et al. Klk8 is required for microabscess formation in a mouse imiquimod model of psoriasis. Exp. Dermatol. 24, 887 (2015).","journal-title":"Exp. Dermatol."},{"key":"3028_CR33","doi-asserted-by":"publisher","first-page":"5834","DOI":"10.1074\/jbc.M607998200","volume":"282","author":"M Kishibe","year":"2007","unstructured":"Kishibe, M. et al. Kallikrein 8 is involved in skin desquamation in cooperation with other kallikreins. J. Biol. Chem. 282, 5834 (2007).","journal-title":"J. Biol. Chem."},{"key":"3028_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature11606","volume":"492","author":"MT McCabe","year":"2012","unstructured":"McCabe, M. T. et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 492, 108 (2012).","journal-title":"Nature"},{"key":"3028_CR35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/carcin\/bgu238","volume":"36","author":"H Takeshima","year":"2015","unstructured":"Takeshima, H., Wakabayashi, M., Hattori, N., Yamashita, S. & Ushijima, T. Identification of coexistence of DNA methylation and H3K27me3 specifically in cancer cells as a promising target for epigenetic therapy. Carcinogenesis 36, 192 (2015).","journal-title":"Carcinogenesis"},{"key":"3028_CR36","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1177\/1933719118765966","volume":"26","author":"BB Huang","year":"2019","unstructured":"Huang, B. B. et al. Effect of high-fat diet on immature female mice and messenger and noncoding RNA expression profiling in ovary and white adipose tissue. Reprod. Sci. 26, 1360 (2019).","journal-title":"Reprod. Sci."},{"key":"3028_CR37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.domaniend.2017.12.002","volume":"63","author":"LF Schutz","year":"2018","unstructured":"Schutz, L. F., Hurst, R. E., Schreiber, N. B. & Spicer, L. J. Transcriptome profiling of bovine ovarian theca cells treated with fibroblast growth factor 9. Domest. Anim. Endocrinol. 63, 48 (2018).","journal-title":"Domest. Anim. Endocrinol."},{"key":"3028_CR38","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L van der Fits","year":"2009","unstructured":"van der Fits, L. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J. Immunol. 182, 5836 (2009).","journal-title":"J. Immunol."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03028-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03028-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03028-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T06:51:53Z","timestamp":1698216713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-03028-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,3]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["3028"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-03028-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,3]]},"assertion":[{"value":"16 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"826"}}